An invitation-only Paris panel united global medical leaders to redefine recovery through the concept of the Regenerative ...
CEO Abizer Gaslightwala discusses the Company’s recent announcement around its ADC pipeline expansion and IP strategyCompany also discusses its ...
Atossa Therapeutics Issues Letter to Shareholders Highlighting 2025 Accomplishments and 2026 Outlook
Atossa Therapeutics, Inc. ("Atossa" or the "Company"), a clinical-stage biopharmaceutical company developing novel therapies in oncology and other areas of high unmet need, today issued a letter to ...
The gut microbiota plays a crucial role in regulating host immunity, metabolism and inflammation, with accumulating evidence ...
NurExone Biologic Inc. (TSXV: NRX) (OTCQB: NRXBF) (FSE: J90) ("NurExone" or the "Company"), a biopharmaceutical company developing ...
Sanofi’s rilzabrutinib receives US FDA breakthrough therapy & Japanese orphan drug designations to treat warm autoimmune haemolytic anaemia: Paris Wednesday, February 11, 2026, ...
Batch-to-batch consistency is a core factor in biological production for clinical manufacturing. Four independent NurExone ...
PBGENE-DMD is Precision's wholly-owned, first-in-class in vivo gene editing program utilizing a gene excision approach intended to permanently correct the dystrophin gene in patients with mutations ...
Press Trust of India on MSN
ICFAI Business School (IBS) selection process for MBA/PGPM 2026-28 | 2-year full time program
HYDERABAD, India, Feb ...
An efficient neural screening approach rapidly identifies circuit modules governing distinct behavioral transitions in response to pathogen exposure.
Drivers who mourn the stick-shift box may yet have reasons to be optimistic. Could the very idea of manual shifting be relevant in an EV world?
Some results have been hidden because they may be inaccessible to you
Show inaccessible results